These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9507762)

  • 1. [Study of the distribution of human filariasis in West Province of Cameroon].
    Kamgno J; Bouchité B; Baldet T; Folefack G; Godin C; Boussinesq M
    Bull Soc Pathol Exot; 1997; 90(5):327-30. PubMed ID: 9507762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
    Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon.
    Boussinesq M; Gardon J; Kamgno J; Pion SD; Gardon-Wendel N; Chippaux JP
    Ann Trop Med Parasitol; 2001 Jul; 95(5):495-507. PubMed ID: 11487371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin.
    Esum M; Wanji S; Tendongfor N; Enyong P
    Trans R Soc Trop Med Hyg; 2001; 95(6):673-6. PubMed ID: 11816443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperendemic loaiasis in the Tikar plain, shrub savanna region of Cameroon].
    Kamgno J; Boussinesq M
    Bull Soc Pathol Exot; 2001 Nov; 94(4):342-6. PubMed ID: 11845532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of concomitant infections due to Loa loa, Mansonella perstans, and Onchocerca volvulus in rain forest villages of Cameroon.
    Wanji S; Tendongfor N; Esum M; Ndindeng S; Enyong P
    Med Microbiol Immunol; 2003 Feb; 192(1):15-21. PubMed ID: 12592559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon.
    Wanji S; Tendongfor N; Esum M; Yundze SS; Taylor MJ; Enyong P
    Filaria J; 2005 Apr; 4(1):2. PubMed ID: 15817124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment.
    Wanji S; Kengne-Ouafo JA; Esum ME; Chounna PW; Tendongfor N; Adzemye BF; Eyong JE; Jato I; Datchoua-Poutcheu FR; Kah E; Enyong P; Taylor DW
    Parasit Vectors; 2015 Apr; 8():202. PubMed ID: 25886166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Country-wide rapid epidemiological mapping of onchocerciasis (REMO) in Cameroon.
    Macé JM; Boussinesq M; Ngoumou P; Enyegue Oye J; Koéranga A; Godin C
    Ann Trop Med Parasitol; 1997 Jun; 91(4):379-91. PubMed ID: 9290845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid assessment method for prevalence and intensity of Loa loa infection.
    Takougang I; Meremikwu M; Wandji S; Yenshu EV; Aripko B; Lamlenn SB; Eka BL; Enyong P; Meli J; Kale O; Remme JH
    Bull World Health Organ; 2002; 80(11):852-8. PubMed ID: 12481206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: impact on control strategies.
    Tekle AH; Zoure H; Wanji S; Leak S; Noma M; Remme JH; Amazigo U
    Acta Trop; 2011 Sep; 120 Suppl 1():S81-90. PubMed ID: 20525531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of 3 years ivermectin treatment on onchocerciasis in Yanomami communities in the Brazilian Amazon.
    Banic DM; Calvão-Brito RH; Marchon-Silva V; Schuertez JC; de Lima Pinheiro LR; da Costa Alves M; Têva A; Maia-Herzog M
    Acta Trop; 2009 Nov; 112(2):125-30. PubMed ID: 19615327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.
    Katabarwa M; Eyamba A; Habomugisha P; Lakwo T; Ekobo S; Kamgno J; Kuete T; Ndyomugyenyi R; Onapa A; Salifou M; Ntep M; Richards FO
    Trop Med Int Health; 2008 Sep; 13(9):1196-203. PubMed ID: 18631308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of epilepsy in a village in the Littoral Province of Cameroon.
    Prischich F; De Rinaldis M; Bruno F; Egeo G; Santori C; Zappaterreno A; Fattouch J; Di Bonaventura C; Bada J; Russo G; Pizzuti A; Cardona F; Sa'a ; Vullo V; Giallonardo AT; D'Erasmo E; Pelliccia A; Vanacore N
    Epilepsy Res; 2008 Dec; 82(2-3):200-10. PubMed ID: 18976884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Control of onchocerciasis with ivermectin: results of a mass campaign in northern Cameroon].
    Prod'hon J; Boussinesq M; Fobi G; Prud'hom JM; Enyong P; Lafleur C; Quillévéré D
    Bull World Health Organ; 1991; 69(4):443-50. PubMed ID: 1934238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephropathy in Cameroon: evidence for filarial derived immune-complex pathogenesis in some cases.
    Ngu JL; Chatelanat F; Leke R; Ndumbe P; Youmbissi J
    Clin Nephrol; 1985 Sep; 24(3):128-34. PubMed ID: 3862488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis.
    Twum-Danso NA; Meredith SE
    Trop Med Int Health; 2003 Sep; 8(9):820-31. PubMed ID: 12950668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications.
    Pion SD; Filipe JA; Kamgno J; Gardon J; Basáñez MG; Boussinesq M
    Parasitology; 2006 Jul; 133(Pt 1):101-9. PubMed ID: 16764737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Market survey of loiasis: prevalence and adverse reactions to ivermectin using a rapid procedure for loiasis.
    Ibidapo CA; Akinsanya B; Adeoye GO; Otubanjo AO; Okeke P; Okwuzu J; Adejai EO; Braide E
    West Indian Med J; 2008 Mar; 57(2):152-6. PubMed ID: 19565959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and intensity of Loa loa infection over twenty-three years in three communities of the Mbalmayo health district (Central Cameroon).
    Mogoung-Wafo AE; Nana-Djeunga HC; Domche A; Fossuo-Thotchum F; Bopda J; Mbickmen-Tchana S; Djomo-Kamga H; Kamgno J
    BMC Infect Dis; 2019 Feb; 19(1):146. PubMed ID: 30760228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.